F R Appelbaum|H M Shulman - JoVE Visualize

Showing results (401-410 of 464) with videos related to

Pageof 47

Sort By:

Leukemia Research|September 4, 1999

A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia Southwest Oncology Group StudyC Karanes, K J Kopecky, D R Head, et al.

Transplantation|January 5, 2002

Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host diseaseA I Benito, T Furlong, P J Martin, et al.

Blood|October 1, 1991

Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaqueD C Matthews, F R Appelbaum, J F Eary, et al.

Blood|February 1, 1981

Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppressionK M Sullivan, H M Shulman, R Storb, et al.

Bone Marrow Transplantation|February 18, 1998

Acute pancreatitis in marrow transplant patients: prevalence at autopsy and risk factor analysisC W Ko, T Gooley, H G Schoch, et al.

Blood|July 1, 1994

HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3A A Scott, D R Head, K J Kopecky, et al.

Bone Marrow Transplantation|September 1, 1991

Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapyR H Van der Jagt, F R Appelbaum, F B Petersen, et al.

Blood|July 27, 1999

Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group StudyC P Leith, K J Kopecky, I M Chen, et al.

Blood|August 10, 1999

Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndromeD C Matthews, F R Appelbaum, J F Eary, et al.

Blood|September 25, 1999

A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipientsP J Martin, S D Rowley, C Anasetti, et al.

Pageof 47

Showing results (401-410 of 464) with videos related to

Sort By:

Pageof 47

Leukemia Research|September 4, 1999

A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia Southwest Oncology Group StudyC Karanes, K J Kopecky, D R Head, et al.

Transplantation|January 5, 2002

Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host diseaseA I Benito, T Furlong, P J Martin, et al.

Blood|October 1, 1991

Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaqueD C Matthews, F R Appelbaum, J F Eary, et al.

Blood|February 1, 1981

Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppressionK M Sullivan, H M Shulman, R Storb, et al.

Bone Marrow Transplantation|February 18, 1998

Acute pancreatitis in marrow transplant patients: prevalence at autopsy and risk factor analysisC W Ko, T Gooley, H G Schoch, et al.

Blood|July 1, 1994

HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3A A Scott, D R Head, K J Kopecky, et al.

Bone Marrow Transplantation|September 1, 1991

Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapyR H Van der Jagt, F R Appelbaum, F B Petersen, et al.

Blood|July 27, 1999

Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group StudyC P Leith, K J Kopecky, I M Chen, et al.

Blood|August 10, 1999

Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndromeD C Matthews, F R Appelbaum, J F Eary, et al.

Blood|September 25, 1999

A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipientsP J Martin, S D Rowley, C Anasetti, et al.

Pageof 47